Resection of the epileptogenic lesion abolishes seizures and reduces inflammatory cytokines of patients with temporal lobe epilepsy

Journal of Neuroimmunology

Volumn 254, Issue 1-2, 2013, Pages 125-130

  Quirico Santos, Thereza ^a   Meira, Isabella D'Andrea ^a,b   Gomes, Aline C ^a   Pereira, Valeria C ^b   Pinto, Moises ^b   Monteiro, Marisa ^b   Souza, Jorge M ^b   Alves Leon, Soniza V ^b  

^a FLUMINENSE FEDERAL UNIVERSITY   (Brazil)

^b FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

Cytokine; Lobectomy; Mesial temporal lobe epilepsy; Neuroinflammation; Seizure

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; CYTOKINE; INTERLEUKIN 1BETA; INTERLEUKIN 6; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; OXCARBAZEPINE; PHENYTOIN; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA; VALPROIC ACID;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN REGULATION; EPILEPTIC FOCUS; FEMALE; HUMAN; MALE; NERVE CELL DEGENERATION; NERVOUS SYSTEM INFLAMMATION; OUTCOME ASSESSMENT; PATHOGENESIS; PRIORITY JOURNAL; PROSPECTIVE STUDY; SEIZURE; TEMPORAL LOBE EPILEPSY; TEMPORAL LOBECTOMY;

ADOLESCENT; ADULT; ANTERIOR TEMPORAL LOBECTOMY; CYTOKINES; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPILEPSY, TEMPORAL LOBE; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; STATISTICS, NONPARAMETRIC; YOUNG ADULT;

EID: 84871678060     PISSN: 01655728     EISSN: 18728421     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2012.08.004     Document Type: Article

References (42)

1. Aarli J.A. Epilepsy and the immune system. Arch. Neurol. 2000, 57:1689-1692.
2. Alapirtti T., Rinta S., Hulkkonen J., Makinen R., Keranen T., Peltola J. Interleukin-6, interleukin-1 receptor antagonist and interleukin-1beta production in patients with focal epilepsy: a video-EEG study. J. Neurol. Sci. 2009, 280:94-97.
3. Aronica E., Crino P.B. Inflammation in epilepsy: clinical observations. Epilepsia 2011, 52:26-32.
4. Balosso S., Ravizza T., Pierucci M., Calcagno E., Invernizzi R., Di Giovanni G., Esposito E., Vezzani A. Molecular and functional interactions between tumor necrosis factor-alpha receptors and the glutamatergic system in the mouse hippocampus: implications for seizure susceptibility. Neuroscience 2009, 161:293-300.
5. Bauer S., Cepok S., Todorova-Rudolph A., Nowak M., Köller M., Lorenz R., Oertel W.H., Rosenow F., Hemmer B., Hamer H.M. Etiology and site of temporal lobe epilepsy influence postictal cytokine release. Epilepsy Res. 2009, 86:82-88.
6. Berg A.T. Identification of pharmacoresistant epilepsy. Neurol. Clin. 2009, 27:1003-1013.
7. Boche D., Cunningham C., Docagne F., Scott H., Perry V.H. TGFbeta1 regulates the inflammatory response during chronic neurodegeneration. Neurobiol. Dis. 2006, 22:638-650.
8. Cacheaux L.P., Ivens S., David Y., Lakhter A.J., Bar-Klein G., Shapira M., Heinemann U., Friedman A., Kaufer D. Transcriptome profiling reveals TGF-beta signaling involvement in epileptogenesis. J. Neurosci. 2009, 29:8927-8935.
9. Cheng X., Yang L., He P., Li R., Shen Y. Differential activation of tumor necrosis factor receptors distinguishes between brains from Alzheimer's disease and non-demented patients. J. Alzheimers Dis. 2010, 19:621-630.
10. De Simoni M.G., Perego C., Ravizza T., Moneta D., Conti M., Marchesi F., De Luigi A., Garattini S., Vezzani A. Inflammatory cytokines and related genes are induced in the rat hippocampus by limbic status epilepticus. Eur. J. Neurosci. 2000, 12:2623-2633.
11. Engel J. ILAE classification of epilepsy syndromes. Epilepsy Res. 2006, 70(Suppl. 1):S5-S10.
12. Fabene P.F., Bramanti P., Constantin G. The emerging role for chemokines in epilepsy. J. Neuroimmunol. 2010, 224:22-27.
13. Figiel I. Pro-inflammatory cytokine TNF-alpha as a neuroprotective agent in the brain. Acta Neurobiol. Exp. (Wars) 2008, 68:526-534.
14. Flood C., Akinwunmi J., Lagord C., Daniel M., Berry M., Jackowski A., Logan A. Transforming growth factor-[bgr]1 in the cerebrospinal fluid of patients with subarachnoid hemorrhage[colon] titers derived from exogenous and endogenous sources. J. Cereb. Blood Flow Metab. 2001, 21:157-162.
15. Friedman A., Dingledine R. Molecular cascades that mediate the influence of inflammation on epilepsy. Epilepsia 2011, 52:33-39.
16. Hakkoum D., Stoppini L., Muller D. Interleukin-6 promotes sprouting and functional recovery in lesioned organotypic hippocampal slice cultures. J. Neurochem. 2007, 100:747-757.
17. Heinrich P.C., Behrmann I., Haan S., Hermanns H.M., Muller-Newen G., Schaper F. Principles of interleukin (IL)-6-type cytokine signalling and its regulation. Biochem. J. 2003, 374:1-20.
18. Hulkkonen J., Koskikallio E., Rainesalo S., Keranen T., Hurme M., Peltola J. The balance of inhibitory and excitatory cytokines is differently regulated in vivo and in vitro among therapy resistant epilepsy patients. Epilepsy Res. 2004, 59:199-205.
19. Ichiyama T., Okada K., Lipton J.M., Matsubara T., Hayashi T., Furukawa S. Sodium valproate inhibits production of TNF-alpha and IL-6 and activation of NF-kappaB. Brain Res. 2000, 857:246-251.
20. Jankowsky J.L., Patterson P.H. The role of cytokines and growth factors in seizures and their sequelae. Prog. Neurobiol. 2001, 63:125-149.
21. Jara J.H., Singh B.B., Floden A.M., Combs C.K. Tumor necrosis factor alpha stimulates NMDA receptor activity in mouse cortical neurons resulting in ERK-dependent death. J. Neurochem. 2007, 100:1407-1420.
22. Jeha L.E., Najm I.M., Bingaman W.E., Khandwala F., Widdess-Walsh P., Morris H.H., Dinner D.S., Nair D., Foldvary-Schaeffer N., Prayson R.A., Comair Y., O'Brien R., Bulacio J., Gupta A., Luders H.O. Predictors of outcome after temporal lobectomy for the treatment of intractable epilepsy. Neurology 2006, 66:1938-1940.
23. Krsek P., Tichy M., Hajek M., Dezortova M., Zamecnick J., Zedka M., Stibitzova R., Komarek V. Successful epilepsy surgery with a resection contralateral to a suspected epileptogenic lesion. Epileptic Disord. 2007, 9:82-98.
24. Lehtimaki K.A., Keranen T., Palmio J., Makinen R., Hurme M., Honkaniemi J., Peltola J. Increased plasma levels of cytokines after seizures in localization-related epilepsy. Acta Neurol. Scand. 2007, 116:226-230.
25. Lehtimaki K.A., Keranen T., Palmio J., Peltola J. Levels of IL-1beta and IL-1ra in cerebrospinal fluid of human patients after single and prolonged seizures. Neuroimmunomodulation 2010, 17:19-22.
26. Lehtimaki K.A., Liimatainen S., Peltola J., Arvio M. The serum level of interleukin-6 in patients with intellectual disability and refractory epilepsy. Epilepsy Res. 2011, 95:184-187.
27. Lu Y., Xue T., Yuan J., Li Y., Wu Y., Xi Z., Xiao Z., Chen Y., Wang X. Increased expression of TGFbeta type I receptor in brain tissues of patients with temporal lobe epilepsy. Clin. Sci. (Lond.) 2009, 117:17-22.
28. Luders H., Acharya J., Baumgartner C., Benbadis S., Bleasel A., Burgess R., Dinner D.S., Ebner A., Foldvary N., Geller E., Hamer H., Holthausen H., Kotagal P., Morris H., Meencke H.J., Noachtar S., Rosenow F., Sakamoto A., Steinhoff B.J., Tuxhorn I., Wyllie E. Semiological seizure classification. Epilepsia 1998, 39:1006-1013.
29. Minami M., Kuraishi Y., Satoh M. Effects of kainic acid on messenger RNA levels of IL-1 beta, IL-6, TNF alpha and LIF in the rat brain. Biochem. Biophys. Res. Commun. 1991, 176:593-598.
30. Mlodzikowska-Albrecht J., Steinborn B., Zarowski M. Cytokines, epilepsy and epileptic drugs-is there a mutual influence?. Pharmacol. Rep. 2007, 59:129-138.
31. Nowak M., Bauer S., Haag A., Cepok S., Todorova-Rudolph A., Tackenberg B., Norwood B., Oertel W.H., Rosenow F., Hemmer B., Hamer H.M. Interictal alterations of cytokines and leukocytes in patients with active epilepsy. Brain Behav. Immun. 2011, 25:423-428.
32. Peltola J., Palmio J., Korhonen L., Suhonen J., Miettinen A., Hurme M., Lindholm D., Keranen T. Interleukin-6 and interleukin-1 receptor antagonist in cerebrospinal fluid from patients with recent tonic-clonic seizures. Epilepsy Res. 2000, 41:205-211.
33. Spencer S.S. Substrates of localization-related epilepsies: biologic implications of localizing findings in humans. Epilepsia 1998, 39:114-123.
34. Thomas P.S. Tumour necrosis factor-[agr]: the role of this multifunctional cytokine in asthma. Immunol. Cell Biol. 2001, 79:132-140.
35. Vale F.L., Effio E., Arredondo N., Bozorg A., Wong K., Martinez C., Downes K., Tatum W.O., Benbadis S.R. Efficacy of temporal lobe surgery for epilepsy in patients with negative MRI for mesial temporal lobe sclerosis. J. Clin. Neurosci. 2012, 19:101-106.
36. Veroni C., Gabriele L., Canini I., Castiello L., Coccia E., Remoli M.E., Columba-Cabezas S., Aricò E., Aloisi F., Agresti C. Activation of TNF receptor 2 in microglia promotes induction of anti-inflammatory pathways. Mol. Cell. Neurosci. 2010, 45:234-244.
37. Vezzani A., Balosso S., Ravizza T. The role of cytokines in the pathophysiology of epilepsy. Brain Behav. Immun. 2008, 22:797-803.
38. Vezzani A., French J., Bartfai T., Baram T.Z. The role of inflammation in epilepsy. Nat. Rev. Neurol. 2011, 7:31-40.
39. Vivien D., Ali C. Transforming growth factor-[beta] signalling in brain disorders. Cytokine Growth Factor Rev. 2006, 17:121-128.
40. Wachs F.P., Winner B., Couillard-Despres S., Schiller T., Aigner R., Winkler J., Bogdahn U., Aigner L. Transforming growth factor-beta1 is a negative modulator of adult neurogenesis. J. Neuropathol. Exp. Neurol. 2006, 65:358-370.
41. Wajant H., Pfizenmaier K., Scheurich P. Tumor necrosis factor signaling. Cell Death Differ. 2003, 10:45-65.
42. Wieser H.G. ILAE Commission Report. Mesial temporal lobe epilepsy with hippocampal sclerosis. Epilepsia 2004, 45:695-714.